glp 1 drugs fda approved for weight loss The has the first GLP-1 pill loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular Compound versions of GLP-1 drugs

Funded by a two-year, nearly $350,000 grant from the National Institutes of Healths National Institute on Aging, the University of Cincinnatis Shawn Xiong, PhD, is analyzing real-world patient data to learn more about how GLP-1 drugs affect people with mild cognitive impairment, a common precursor to Alzheimers disease

To what extent this relationship translates into alterations in HbA 1c , time in range and total daily dose of insulin in patients with ideal body weight and type 1 diabetes is yet to be determined

Further research is warranted to explore long-term outcomes and optimize treatment protocols for this patient population

2018 [updated 2019, cited March 10, 2025]

As GLP-1 therapy progresses and weight loss occurs, your provider may need to reduce or discontinue some antihypertensive medications to prevent symptomatic low blood pressure, but this decision requires medical supervision and regular blood pressure monitoring

Consequently, many patients discontinue therapy or never begin treatment at all